Cargando…

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

BACKGROUND: The estimation of the burden of disease attributable to fatty liver requires studies performed in the general population. METHODS: The Bagnacavallo Study was performed between October 2005 and March 2009. All the citizens of Bagnacavallo (Ravenna, Italy) aged 30 to 60 years as of January...

Descripción completa

Detalles Bibliográficos
Autores principales: Foschi, Francesco Giuseppe, Bedogni, Giorgio, Domenicali, Marco, Giacomoni, Pierluigi, Dall’Aglio, Anna Chiara, Dazzani, Francesca, Lanzi, Arianna, Conti, Fabio, Savini, Sara, Saini, Gaia, Bernardi, Mauro, Andreone, Pietro, Gastaldelli, Amalia, Gardini, Andrea Casadei, Tiribelli, Claudio, Bellentani, Stefano, Stefanini, Giuseppe Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262973/
https://www.ncbi.nlm.nih.gov/pubmed/30486798
http://dx.doi.org/10.1186/s12876-018-0906-8
_version_ 1783375210699816960
author Foschi, Francesco Giuseppe
Bedogni, Giorgio
Domenicali, Marco
Giacomoni, Pierluigi
Dall’Aglio, Anna Chiara
Dazzani, Francesca
Lanzi, Arianna
Conti, Fabio
Savini, Sara
Saini, Gaia
Bernardi, Mauro
Andreone, Pietro
Gastaldelli, Amalia
Gardini, Andrea Casadei
Tiribelli, Claudio
Bellentani, Stefano
Stefanini, Giuseppe Francesco
author_facet Foschi, Francesco Giuseppe
Bedogni, Giorgio
Domenicali, Marco
Giacomoni, Pierluigi
Dall’Aglio, Anna Chiara
Dazzani, Francesca
Lanzi, Arianna
Conti, Fabio
Savini, Sara
Saini, Gaia
Bernardi, Mauro
Andreone, Pietro
Gastaldelli, Amalia
Gardini, Andrea Casadei
Tiribelli, Claudio
Bellentani, Stefano
Stefanini, Giuseppe Francesco
author_sort Foschi, Francesco Giuseppe
collection PubMed
description BACKGROUND: The estimation of the burden of disease attributable to fatty liver requires studies performed in the general population. METHODS: The Bagnacavallo Study was performed between October 2005 and March 2009. All the citizens of Bagnacavallo (Ravenna, Italy) aged 30 to 60 years as of January 2005 were eligible. Altered liver enzymes were defined as alanine transaminase > 40 U/l and/or aspartate transaminase > 37 U/l. RESULTS: Four thousand and thirty-three (58%) out of 6920 eligible citizens agreed to participate and 3933 (98%) had complete data. 393 (10%) of the latter had altered liver enzymes and 3540 had not. After exclusion of subjects with HBV or HCV infection, liver ultrasonography was available for 93% of subjects with altered liber enzymes and 52% of those with normal liver enzymes. The prevalence of fatty liver, non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) was 0.74 (95%CI 0.70 to 0.79) vs. 0.35 (0.33 to 0.37), 0.46 (0.41 to 0.51) vs. 0.22 (0.21 to 0.24) and 0.28 (0.24 to 0.33) vs. 0.13 (0.11 to 0.14) in citizens with than in those without altered liver enzymes. Ethanol intake was not associated and all the components of the metabolic syndrome (MS) were associated with fatty liver. All potential risk factors were associated with a lower odds of normal liver vs. NAFLD while they were unable to discriminate AFLD from NAFLD. CONCLUSIONS: Fatty liver as a whole was highly prevalent in Bagnacavallo in 2005/9 and was more common among citizens with altered liver enzymes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0906-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6262973
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62629732018-12-10 Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study Foschi, Francesco Giuseppe Bedogni, Giorgio Domenicali, Marco Giacomoni, Pierluigi Dall’Aglio, Anna Chiara Dazzani, Francesca Lanzi, Arianna Conti, Fabio Savini, Sara Saini, Gaia Bernardi, Mauro Andreone, Pietro Gastaldelli, Amalia Gardini, Andrea Casadei Tiribelli, Claudio Bellentani, Stefano Stefanini, Giuseppe Francesco BMC Gastroenterol Research Article BACKGROUND: The estimation of the burden of disease attributable to fatty liver requires studies performed in the general population. METHODS: The Bagnacavallo Study was performed between October 2005 and March 2009. All the citizens of Bagnacavallo (Ravenna, Italy) aged 30 to 60 years as of January 2005 were eligible. Altered liver enzymes were defined as alanine transaminase > 40 U/l and/or aspartate transaminase > 37 U/l. RESULTS: Four thousand and thirty-three (58%) out of 6920 eligible citizens agreed to participate and 3933 (98%) had complete data. 393 (10%) of the latter had altered liver enzymes and 3540 had not. After exclusion of subjects with HBV or HCV infection, liver ultrasonography was available for 93% of subjects with altered liber enzymes and 52% of those with normal liver enzymes. The prevalence of fatty liver, non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) was 0.74 (95%CI 0.70 to 0.79) vs. 0.35 (0.33 to 0.37), 0.46 (0.41 to 0.51) vs. 0.22 (0.21 to 0.24) and 0.28 (0.24 to 0.33) vs. 0.13 (0.11 to 0.14) in citizens with than in those without altered liver enzymes. Ethanol intake was not associated and all the components of the metabolic syndrome (MS) were associated with fatty liver. All potential risk factors were associated with a lower odds of normal liver vs. NAFLD while they were unable to discriminate AFLD from NAFLD. CONCLUSIONS: Fatty liver as a whole was highly prevalent in Bagnacavallo in 2005/9 and was more common among citizens with altered liver enzymes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0906-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-28 /pmc/articles/PMC6262973/ /pubmed/30486798 http://dx.doi.org/10.1186/s12876-018-0906-8 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Foschi, Francesco Giuseppe
Bedogni, Giorgio
Domenicali, Marco
Giacomoni, Pierluigi
Dall’Aglio, Anna Chiara
Dazzani, Francesca
Lanzi, Arianna
Conti, Fabio
Savini, Sara
Saini, Gaia
Bernardi, Mauro
Andreone, Pietro
Gastaldelli, Amalia
Gardini, Andrea Casadei
Tiribelli, Claudio
Bellentani, Stefano
Stefanini, Giuseppe Francesco
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
title Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
title_full Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
title_fullStr Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
title_full_unstemmed Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
title_short Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
title_sort prevalence of and risk factors for fatty liver in the general population of northern italy: the bagnacavallo study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262973/
https://www.ncbi.nlm.nih.gov/pubmed/30486798
http://dx.doi.org/10.1186/s12876-018-0906-8
work_keys_str_mv AT foschifrancescogiuseppe prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT bedognigiorgio prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT domenicalimarco prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT giacomonipierluigi prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT dallaglioannachiara prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT dazzanifrancesca prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT lanziarianna prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT contifabio prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT savinisara prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT sainigaia prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT bernardimauro prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT andreonepietro prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT gastaldelliamalia prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT gardiniandreacasadei prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT tiribelliclaudio prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT bellentanistefano prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy
AT stefaninigiuseppefrancesco prevalenceofandriskfactorsforfattyliverinthegeneralpopulationofnorthernitalythebagnacavallostudy